Hong Kong Stock Movement Update: Biopharmaceutical stocks rebound strongly, PEGBIO CO-B rises 23%, METASPACEX falls 15%

In the past hour, the Hong Kong stock market has shown a clear divergence, with the strong performance of the pharmaceutical sector attracting a significant inflow of funds, particularly in stocks like PEGBIO CO-B and BAO PHARMA-B, which have seen notable gains, indicating an increase in short-term enthusiasm. Meanwhile, technology stocks appear relatively weak, with the declines of METASPACEX and Yimu Group drawing market attention, suggesting a rapid switch of funds between different sectors. Overall volatility is high, and the sentiment of short-term traders is fluctuating, with a faster market rhythm. The stock with the largest movement in the past hour, PEGBIO CO-B, has surged by 23.15%, rapidly attracting funds under the influence of the pharmaceutical sector, leading to heightened short-term sentiment and drawing the attention of many investors. The strong performance of this stock seems to inject vitality into the entire sector, driving up other related stocks. Strong stocks include: 1. BAO PHARMA-B: up 18.49%, with continuous inflow of funds against the backdrop of increased market enthusiasm, showing impressive short-term performance. 2. XUANZHUBIO-B: up 16.00%, recent strong trends reflect market confidence in its future development. 3. Jingjiu Kangliao: up 15.87%, gaining favor from investors as the pharmaceutical sector becomes active. 4. Zhongke Group Holdings - New: up 15.38%, with significant short-term fund support amid high market sentiment. 5. Silu Di Pharmaceutical Co., Ltd.: up 15.12%, with the stock's rise reflecting optimistic expectations for the pharmaceutical industry